These data were also confirmed ex-vivo at the end of the study (96 h) and can be linked to the specificity of AT101 for the GPC1 protein expressed in the BXPC3 tumor masses, allowing for durable localization at the tumor site. This evidence concerns the gene GPC1 and neoplasm.